Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cardarine
2. Gw 1516
3. Gw 501516
4. Gw-1516
5. Gw-501516
6. Gw1516
7. Gw501516
1. 317318-70-0
2. Gw501516
3. Gw 501516
4. Gw-501516
5. Gsk-516
6. Cardarine
7. Gw1516
8. Gw 1516
9. Unii-7i2ha1nu22
10. Gw-1516
11. 2-(4-((2-(4-(trifluoromethyl)phenyl)-4-methylthiazol-5-yl)methylthio)-2-methylphenoxy)acetic Acid
12. 2-(2-methyl-4-(((4-methyl-2-(4-(trifluoromethyl)phenyl)thiazol-5-yl)methyl)thio)phenoxy)acetic Acid
13. 2-[2-methyl-4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]methylsulfanyl]phenoxy]acetic Acid
14. Gw-516
15. Chembl38943
16. 7i2ha1nu22
17. {2-methyl-4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]phenoxy}acetic Acid
18. Chebi:73726
19. 2-{2-methyl-4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]phenoxy}acetic Acid
20. Gw501,516
21. Gw 501,516
22. Gw-501,516
23. Gsk 516
24. Gw501516 (endurobol)
25. Schembl68714
26. 2-[2-methyl-4-[[[4-methyl-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl]methyl]thio]phenoxy]acetic Acid
27. Mls006010753
28. Endurobol;gw501516
29. Gtpl2687
30. Dtxsid3041037
31. Bdbm28661
32. Ex-a723
33. Hms3674c03
34. Hms3744o09
35. Bcp21491
36. Zinc1549989
37. Mfcd09033000
38. Pdsp1_000255
39. Pdsp2_000254
40. S5615
41. Akos015965103
42. Ccg-269268
43. Cs-0438
44. Db05416
45. Ex-3881
46. Sb19569
47. Gw501516(g)
48. Gw501516(gsk-516)
49. Ncgc00241455-01
50. Ncgc00241455-02
51. Ncgc00241455-08
52. Ac-23001
53. Hy-10838
54. Smr004701706
55. Am20040157
56. A26949
57. Gw501516, >=98% (hplc)
58. 318g700
59. 6t-0058
60. Benzenesulfonylchloride,4-(2-methylpropyl)-(9ci)
61. J-018519
62. Q5515069
63. Brd-k14880289-001-01-4
64. (2-methyl-4-(((4-methyl-2-(4-(trifluoromethyl)phenyl)-1,3-thiazol-5-yl)methyl)thio)phenoxy)acetic Acid
65. {2-methyl-4-{{4-methyl-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl}methylthio}phenoxy}acetic Acid, Analytical Standard
66. {4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]-2-methylphenoxy}acetic Acid
67. 2-(2-methyl-4-((5-methyl-2-(4-(trifluoromethyl)phenyl)thiazol-4-yl)methylthio)phenoxy)acetic Acid;gw 501516
68. 2-{2-methyl-4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-yl}methyl)sulfanyl]phenoxy}acetic Acid
69. 7t1
70. Acetic Acid, (2-methyl-4-(((4-methyl-2-(4-(trifluoromethyl)phenyl)-5-thiazolyl)methyl)thio)phenoxy)-
71. Acetic Acid, 2-[2-methyl-4-[[[4-methyl-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl]methyl]thio]phenoxy]-
| Molecular Weight | 453.5 g/mol |
|---|---|
| Molecular Formula | C21H18F3NO3S2 |
| XLogP3 | 5.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 7 |
| Exact Mass | 453.06802027 g/mol |
| Monoisotopic Mass | 453.06802027 g/mol |
| Topological Polar Surface Area | 113 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 572 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in hyperlipidemia.
This drug regulates fatty acid oxidation in several tissues, such as skeletal muscle and adipose tissue. Overexpression of PPARdelta using a transgenic murine model promotes an increase of muscle oxidative capability. It also plays a major role in the metabolic adaptations to western diet characterized by an excessive amount of saturated fat.
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Endurobol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Endurobol, including repackagers and relabelers. The FDA regulates Endurobol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Endurobol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Endurobol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Endurobol supplier is an individual or a company that provides Endurobol active pharmaceutical ingredient (API) or Endurobol finished formulations upon request. The Endurobol suppliers may include Endurobol API manufacturers, exporters, distributors and traders.
click here to find a list of Endurobol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Endurobol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Endurobol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Endurobol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Endurobol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Endurobol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Endurobol suppliers with NDC on PharmaCompass.
Endurobol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Endurobol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Endurobol GMP manufacturer or Endurobol GMP API supplier for your needs.
A Endurobol CoA (Certificate of Analysis) is a formal document that attests to Endurobol's compliance with Endurobol specifications and serves as a tool for batch-level quality control.
Endurobol CoA mostly includes findings from lab analyses of a specific batch. For each Endurobol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Endurobol may be tested according to a variety of international standards, such as European Pharmacopoeia (Endurobol EP), Endurobol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Endurobol USP).
LOOKING FOR A SUPPLIER?
